טוען...
Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
Pancreatic cancer is the only major cancer with very low survival rates (1%). It is the fourth leading cause of cancer-related death. Hyperactivated growth hormone receptor (GHR) levels have been shown to increase the risk of cancer in general and this pathway is a master regulator of key cellular f...
שמור ב:
| הוצא לאור ב: | Exp Mol Med |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Nature Publishing Group
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221692/ https://ncbi.nlm.nih.gov/pubmed/25301264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2014.61 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|